✦ LIBER ✦

Importance of HER2 and receptor status on the response to adjuvant radiotherapy in high-risk breast cancer — Results from the DBCG82 b&c randomized study

✍ Scribed by M. Kyndi; Sørensen; H. Knudsen; M. Overgaard; H.M. Nielsen; J. Overgaard

Book ID: 118624523
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 132 KB
Volume: 4
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(06)80243-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Estrogen receptor, Progesterone receptor

Estrogen receptor, Progesterone receptor, HER2 status and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trial

✍ Knoop, Ann S.; Lænkholm, Anne-Vibeke; Jensen, Maj-Britt; Nielsen, Kirsten V.; An 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 670 KB

3–36 Study of Failure Pattern Among High

3–36 Study of Failure Pattern Among High-Risk Breast Cancer Patients With or Without Postmastectomy Radiotherapy in Addition to Adjuvant Systemic Therapy: Long-term Results From the Danish Breast Cancer Cooperative Group DBCG 82 b and c Randomized Studies

✍ Chouly, Franz; Lozinski, Alexei 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Carbonic anhydrase IX and response to po

Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of the DBCG82 b and c trials

✍ Marianne Kyndi, Flemming B Sørensen, Helle Knudsen, Jan Alsner… 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 249 KB

The course and prognosis for loco-region

The course and prognosis for loco-regional recurrences among high-risk breast cancer patients receiving adjuvant systemic treatment and randomized to +/− postmastectomy radiotherapy. Long-term results from the Danish DBCG 82b&c studies with 3083 patients

✍ H.M Nielsen; M Overgaard; C Grau; A.R Jensen; J Overgaard 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 185 KB

430 oral Loco-regional control rate in r

430 oral Loco-regional control rate in relation to radiotherapy technique and fractionation in the Danish DBCG 82b & c studies with 1538 high-risk breast cancer patients randomized to postmastectomy radiotherapy

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views